India to Reform New Drugs and Clinical Trials Rules, Halve Processing Time for Test Licences
By amending the New Drugs and Clinical Trials (NDCT) Rules, 2019, the Indian government aims to simplify the requirements and procedures for obtaining test licences and for submitting applications related to Bioavailability/Bioequivalence (BA/BE) studies.
Central Drugs Standard Control Organization (CDSCO | 04/09/2025 | By Dineshwori
Shilpa Medicare Secures CDSCO Approval for NorUDCA Tablets in NAFLD Treatment
Shilpa Medicare Ltd has received approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).
Central Drugs Standard Control Organization (CDSCO | 16/08/2025 | By Dineshwori | 121
India Launches SHRESTH to Strengthen State Drug Regulatory Systems
The initiative, proposed by the Central Drugs Standard Control Organization (CDSCO), aims to drive improvements in the performance of state drug regulatory authorities across India, ensuring drug safety and quality standards are consistently met.
<br />
Central Drugs Standard Control Organization (CDSCO | 13/08/2025 | By Dineshwori | 109
No Physical Applications For WHO-GMP (COPP) Approvals After August 15: CDSCO
The Drugs Controller General of India has directed all zonal and sub-zonal offices of the Central Drugs Standard Control Organization (CDSCO) to stop accepting physical applications for WHO-GMP (Certificate of Pharmaceutical Product – COPP) after August 15, 2025.
Central Drugs Standard Control Organization (CDSCO | 08/08/2025 | By Dineshwori | 141
186 Drug Samples Declared Substandard in May, 49 from Himachal Pradesh: Govt
A total of 186 drug samples were found to be ‘not of standard quality’ (NSQ) in May 2025, with 49 of them manufactured in Himachal Pradesh, Minister of State for Health and Family Welfare Anupriya Patel informed the Rajya Sabha on Tuesday in a written reply.
Central Drugs Standard Control Organization (CDSCO | 23/07/2025 | By Dineshwori | 122
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy